Abridge Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
15:30
Feb 09
David George Senior Research Analyst, Baird a16z
Abridge engagement supports sustainable growth
Abridge is a medical AI tool doctors rave about, described as a trusted deputy. As user growth has massively increased, engagement among new users has held steady and grown slightly, which is a key sign that revenue is sustainable and not fleeting.
Abridge
HIGH
16:49
Jan 26
David George Senior Research Analyst, Baird a16z
Back high-momentum AI app leaders.
The firm targets AI application companies with undeniable momentum that are 'flying off the page,' naming Cursor, Decagon, Abridge, and ElevenLabs as examples of this first bucket of AI strategy.
MED

About Abridge Investor Commentary

Across the available history and selected sources, Buzzberg tracks Abridge across 1 sources: 2 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Latest voices: David George.